Evogene Ltd. EVGN
0.40 USD +0.02 (+6.29%)
At closeNov 11, 2026, 4:35 PM EST
0.38 -0.02 -3.89%
After hours · Nov 11, 4:35 PM ET
0.334 Day range 0.43
0.25 52-week range 1.28
- YTD
- -64.05%
- 1 year
- -68.11%
News
benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session Gainers Sonoma Pharmaceuticals (NASDAQ:SNOA) stock increased by 13.2% to $1.29 during Wednesday's pre-market session. The company's market cap stands at $5.4 million. The company's, Q2 earnings came…
prnewswire.com Evogene Schedules Third Quarter 2026 Financial Results Release Zoom conference call scheduled for November 19, 2026, 9:00 AM ET REHOVOT, Israel, Nov. 5, 2026 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a pioneering company in computational…
benzinga.com Evogene Announces Acute Graft-Versus-Host Disease As Target Indication For Its Internal Drug Discovery Program Advancing a First-in-Class Small-Molecule Therapeutic, Guided by World-Leading Experts, to Address a Multi-Billion-Dollar Unmet Need in Steroid-Refractory PatientsREHOVOT, Israel, Oct. 28, 2026…
prnewswire.com Evogene Announces Acute Graft-Versus-Host Disease (aGVHD) as the Target Indication for Its Internal AI-Driven Drug Discovery Program Advancing a First-in-Class Small-Molecule Therapeutic, Guided by World-Leading Experts, to Address a Multi-Billion-Dollar Unmet Need in Steroid-Refractory Patients REHOVOT, Israel, Oct. 28, 2026…
prnewswire.com Evogene to Participate in Upcoming BIO-Europe in Germany and Drug Discovery Chemistry Europe in Spain Company to Attend BIO-Europe in Cologne, Germany, and Present a Scientific Poster at Drug Discovery Chemistry Europe in Barcelona, Spain REHOVOT, Israel, Oct. 26, 2026 /PRNewswire/ -- Evogene Ltd.…
prnewswire.com Evogene to Participate in U.S. East Coast AI Drug Discovery Roadshow Organized by the Israel Export Institute and TradeIL The roadshow will connect leading Israeli AI-driven drug discovery and biotechnology companies with U.S. investors, pharmaceutical companies, and potential strategic partners REHOVOT, Israel, Oct.…
benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session Gainers Valneva (NASDAQ:VALN) shares rose 20.6% to $7.09 during Wednesday's after-market session. The company's market cap stands at $555.6 million. Profound Medical (NASDAQ:PROF) stock rose 16.98%…
benzinga.com Evogene Reaches Agreement With Pure Capital Group To Resolve Differences Under the terms of the Agreement, two current directors, Dr. Yael Margolin and Mr. Yoshinori Oikawa, who resigned from the Board will be replaced by Pure Capital Group nominees Dr. Adi Zuluf-Shani…
prnewswire.com Evogene and Pure Capital Group Reach Cooperation Agreement to Resolve Differences and Reconstitute Board of Directors REHOVOT, Israel, Oct. 6, 2026 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a pioneer in computational chemistry specializing in the generative design of small molecules for the…
defenseworld.net Critical Review: Evogene (NASDAQ:EVGN) vs. Allarity Therapeutics (NASDAQ:ALLR) Evogene (NASDAQ: EVGN - Get Free Report) and Allarity Therapeutics (NASDAQ: ALLR - Get Free Report) are both small-cap healthcare companies, but which is the better business? We will contrast the two…- benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session Gainers Anbio Biotechnology (NASDAQ:NNNN) stock moved upwards by 16.9% to $6.49 during Friday's after-market session. The market value of their outstanding shares is at $276.0 million. Stablecoin…
- benzinga.com Evogene Discloses That Another Nasdaq 180-Day Period For Regaining Minimum Bid Price Requirement Has Been Extended Until March 29, 2027 Evogene Ltd. (NASDAQ:EVGN) (TASE: EVGN) (the "Company", "Evogene"), a pioneer in computational chemistry specializing in the generative design of small molecules for the pharmaceutical and…
prnewswire.com Evogene Reports Nasdaq Grants Additional 180-Day Period to Regain Minimum Bid Price Compliance REHOVOT, Israel, Sept. 30, 2026 /PRNewswire/ -- Evogene Ltd.
benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session Gainers Evogene (NASDAQ:EVGN) shares increased by 75.0% to $0.72 during Tuesday's after-market session. The company's market cap stands at $4.5 million. AIxCrypto Hldgs (NASDAQ:AIXC) stock moved…
newsfilecorp.com EverGen to Attend the ArcStone-Kingswood Growth Summit 2026 in Toronto Vancouver, British Columbia--(Newsfile Corp. - September 14, 2026) - EverGen Infrastructure Corp. (TSXV: EVGN) (OTCQB: EVGIF) is pleased to announce its participation in the upcoming 3 rd Annual…
defenseworld.net Evogene Ltd. (NASDAQ:EVGN) Short Interest Down 77.2% in August Evogene Ltd. (NASDAQ: EVGN - Get Free Report) was the target of a large drop in short interest in August. As of August 31st, there was short interest totaling 53,001 shares, a drop of 77.2% from the…
prnewswire.com Evogene Responds to Dissident Shareholders: Transformation and Commercial Progress Provide a Clear Path Forward Company urges shareholders to evaluate the significant changes already implemented and vote FOR all Evogene nominees on September 4, 2026, Annual General Meeting REHOVOT, Israel, Aug. 31, 2026…
seekingalpha.com EverGen Infrastructure Corp. (EVGN:CA) Q2 2026 Earnings Call Transcript EverGen Infrastructure Corp. (EVGN:CA) Q2 2026 Earnings Call Transcript
businesswire.com EverGen Infrastructure Reports Q2 2026 Results VANCOUVER, British Columbia--(BUSINESS WIRE)--EverGen Infrastructure Corp. (“EverGen” or the “Company”) (TSXV: EVGN) (OTCQB: EVGIF), today reported financial results as at and for Q2 2026. All…
businesswire.com EverGen Infrastructure Announces Voting Results for the Annual General Meeting of Shareholders Held on August 25, 2026 VANCOUVER, British Columbia--(BUSINESS WIRE)--EverGen Infrastructure Corp. (“EverGen” or the “Company”) (TSXV: EVGN), is pleased to report the voting results from its Annual General Meeting of…
seekingalpha.com EverGen Infrastructure Corp. (EVGN:CA) Shareholder/Analyst Call Prepared Remarks Transcript EverGen Infrastructure Corp. (EVGN:CA) Shareholder/Analyst Call Prepared Remarks Transcript
prnewswire.com Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Evogene Ltd. Shareholders Vote "FOR" the Company's Slate of Highly Qualified Director Nominees Recommendations Reinforce Confidence in Evogene's Strategic Plan and Long-Term Value Creation Strategy Board Urges Shareholders to Vote FOR All Evogene Nominees, and to disregard the Pure Capital…
seekingalpha.com Evogene Ltd. (EVGN) Q2 2026 Earnings Call Transcript Evogene Ltd. (EVGN) Q2 2026 Earnings Call Transcript
benzinga.com CORRECTION: Evogene Q2 EPS $(0.13) Beats $(0.27) Estimate, Sales $347.000K Beat $325.000K Estimate Evogene (NASDAQ:EVGN) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.27) by 51.85 percent. This is a 74 percent increase over losses of $(0.50) per…
prnewswire.com Evogene Reports Second Quarter and First Half 2026 Financial Results Company continues strategic transformation, initiated in 2025, into a focused, AI-driven computational chemistry company, with significant progress across pharmaceutical and agricultural product…
prnewswire.com Evogene Chairman Nir Nimrodi to Join Quarterly Results Call to Address Current Dissident Shareholders Situation Zoom conference call scheduled for August 18, 2026, at 9:00 AM ET REHOVOT, Israel, Aug. 14, 2026 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a pioneering company in computational…
benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session Gainers Jin Medical International (NASDAQ:ZJYL) stock rose 70.7% to $3.67 during Monday's pre-market session. The company's market cap stands at $16.8 million. As per the news, the H1 earnings report…
defenseworld.net Evogene (NASDAQ:EVGN) Stock Price Passes Below 200 Day Moving Average – Here’s Why Evogene Ltd. (NASDAQ: EVGN - Get Free Report) shares crossed below its 200-day moving average during trading on Monday. The stock has a 200-day moving average of $0.75 and traded as low as $0.45.…
prnewswire.com Evogene Schedules Second Quarter 2026 Financial Results Release Zoom conference call scheduled for August 18, 2026, 9:00 AM ET REHOVOT, Israel, July 30, 2026 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a pioneering company in computational…- benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session Gainers Agape ATP (NASDAQ:ATPC) shares rose 17.5% to $2.96 during Wednesday's after-market session. The market value of their outstanding shares is at $2.6 million. China Pharma Holding (AMEX:CPHI)…
benzinga.com Evogene's AgPlenus Subsidiary Introduces Antifungal Potency Predictor AgPlenus Ltd., a company developing novel, sustainable crop protection products and a subsidiary of Evogene Ltd. (NASDAQ:EVGN) (TASE: EVGN), today announced the launch of its Antifungal Potency…- benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session Gainers Virax Biolabs Group (NASDAQ:VRAX) shares rose 178.9% to $8.87 during Thursday's regular session. The market value of their outstanding shares is at $2.5 million. Forte Biosciences…
- benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session Gainers Pulsenmore (NASDAQ:PLSM) stock increased by 152.0% to $8.59 during Wednesday's pre-market session. The company's market cap stands at $22.1 million. Catheter Precision (AMEX:VTAK) shares rose…
- benzinga.com Full Transcript: Evogene Q1 2026 Earnings Call
benzinga.com Evogene Completes First-In-Human Phase 1 Clinical Study Of BMC128, Rationally-Designed Live Bacterial Product Developed By Its Subsidiary, Biomica, In Combination With Nivolumab In Patients With Advanced Solid Tumors Study Results Demonstrated Favorable Safety Profile and Preliminary Signals of Clinical ActivityREHOVOT, Israel, June 2, 2026 /PRNewswire/ -- Evogene Ltd. ("Evogene") (NASDAQ:EVGN) (TASE: EVGN), a…
benzinga.com Evogene Reports Early Results for Cancer Therapy Study, Experimental Treatment Meets Safety Goal in First Human Trial Evogene Ltd. ("Evogene") (NASDAQ:EVGN) (TASE: EVGN), a pioneering computational chemistry company specializing in generative design of small molecules for the pharmaceutical and agricultural…
benzinga.com Earnings Scheduled For May 20, 2026 - benzinga.com Evogene Q1 EPS $(0.60) Misses $(0.27) Estimate, Sales $334.000K Miss $350.000K Estimate Evogene (NASDAQ:EVGN) reported quarterly losses of $(0.60) per share which missed the analyst consensus estimate of $(0.27) by 122.22 percent. This is a 57.89 percent decrease over losses of $(0.38)…
benzinga.com Evogene Receives Nasdaq Noncompliance Notification, Gets Time Through Sept. 28 To Regain Compliance Evogene Ltd. (NASDAQ:EVGN)(TASE: EVGN) (the "Company", "Evogene"), a pioneering company in computational chemistry, specializing in the generative design of small molecules for the pharmaceutical and…
benzinga.com Evogene Earnings Review: Q4 Summary - benzinga.com Earnings Scheduled For March 5, 2026
benzinga.com An Overview of Evogene's Earnings - benzinga.com Evogene Ltd. To Focus On ChemPass AI, Streamlines Operations To Drive Long-Term Value In Pharma And AgTech Updating on Strategic Progress and OutlookREHOVOT, Israel, Feb. 25, 2026 /PRNewswire/ -- Evogene Ltd. (NASDAQ:EVGN) (TASE: EVGN), a pioneering computational chemistry company specializing in the…
- benzinga.com Evogene Partners With Research Group Of Dr. Mark Adams Over Discovery, Optimization Of Small Molecules To Treat Chemotherapy, Targeted Therapy-Resistant Non-small Cell Lung Cancer Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a pioneering computational chemistry company specializing in the generative design of small molecules for the pharmaceutical and agricultural industries…
- benzinga.com Evogene, Systasy And LMU University Hospital Collaborate To Accelerate Development Of Therapies For Hyper-Inflammatory Diseases Driven By Dysregulated Neutrophil Activity The collaboration is supported by a pan-European EUREKA grant, with participation of the Weizmann Institute of ScienceREHOVOT, Israel and MUNICH, Germany, Feb. 11, 2026 /PRNewswire/ -- Evogene Ltd.…
- benzinga.com Evogene Announced An Expanded Phase Of Its Collaboration With Google Cloud That Would Focus On Developing And Integrating Advanced AI Agents Into Evogene's Chempass AI Platform, Its Engine For Small-molecule Discovery And Optimization, Using Google Cloud's Vertex AI Platform This announcement marks the second major milestone in the partnership between Evogene and Google Cloud, following the successful collaboration announced in October 2024. The initial phase focused on…
- benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session
- benzinga.com Evogene's Subsidiary Biomica Inks Exclusive Worldwide Licensing Agreement With Shanghai Lishan Biopharmaceuticals For BMC128, Deal Terms Were Not Disclosed BMC128 was developed by Biomica and is currently completing a Phase 1 clinical study, showing promising early clinical results.BMC128 is a live biopharmaceutical consortium composed of four human gut…
- benzinga.com Evogene Collaborates With Unravel Biosciences To Accelerate Discovery, Optimization Of Small-Molecule Therapeutic Capable Of Restoring Myelin And Reversing Neurological Damage In Demyelinating Diseases Partnership addresses the unmet need for remyelination therapies for multiple sclerosis and other demyelinating conditions by leveraging generative chemistry design and patient-derived predictive…
- benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session